Showing results (221-230 of 647) with videos related to
Sort By:
Pageof 65
Journal of Gastric Cancer|April 11, 2015
Inflammatory myofibroblastic tumor treated with laparoscopic proximal gastrectomy and double-tract anastomosisDong Jin Kim, Wook KimJournal of Gastric Cancer|May 2, 2023
Comprehensive Study of Microsatellite Instability Testing and Its Comparison With Immunohistochemistry in Gastric CancersYujun Park, Soo Kyung Nam, Soo Hyun Seo, et al.Journal of Gastric Cancer|May 2, 2023
Exploratory Analysis of Patients With Gastric/Gastroesophageal Junction Adenocarcinoma With or Without Liver Metastasis From the Phase 3 RAINBOW StudyTakatsugu Ogata, Yukiya Narita, Zev A Wainberg, et al.Journal of Gastric Cancer|May 2, 2023
A Randomized Phase III Study of Patients With Advanced Gastric Adenocarcinoma Without Progression After Six Cycles of XELOX (Capecitabine Plus Oxaliplatin) Followed by Capecitabine Maintenance or Clinical ObservationGuk Jin Lee, Hyunho Kim, Sung Shim Cho, et al.Journal of Gastric Cancer|May 2, 2023
Fatty Acid Binding Protein 5 (FABP5) Promotes Aggressiveness of Gastric Cancer Through Modulation of Tumor ImmunityMei-Qing Qiu, Hui-Jun Wang, Ya-Fei Ju, et al.Journal of Gastric Cancer|April 15, 2021
Adverse Effects of Ligation of an Aberrant Left Hepatic Artery Arising from the Left Gastric Artery during Radical Gastrectomy for Gastric Cancer: a Propensity Score Matching AnalysisSejin Lee, Taeil Son, Jeong Ho Song, et al.Journal of Gastric Cancer|April 15, 2021
A Novel Approach for Gastric Cancer Staging in Elderly Patients Based on the Lymph Node RatioJoonseon Park, Chul Hyo Jeon, So Jung Kim, et al.Journal of Gastric Cancer|October 31, 2022
Impact of the COVID-19 Pandemic on Gastric Cancer Screening in South Korea: Results From the Korean National Cancer Screening Survey (2017-2021)Kyeongmin Lee, Mina Suh, Jae Kwan Jun, et al.Journal of Gastric Cancer|October 31, 2022
PLK2 Single Nucleotide Variant in Gastric Cancer Patients Affects miR-23b-5p BindingPia Pužar Dominkuš, Aner Mesic, Petra HudlerJournal of Gastric Cancer|October 31, 2022
Apatinib as a Third-Line Treatment for HER2-Positive Metastatic Gastric Cancer: A Multi-Center Single-Arm Cohort StudyXin Zhang, Haoran Huo, Yanan Nie, et al.Pageof 65